INTRA-CELLULAR THERAPIES INC (ITCI)
US46116X1019 - Common Stock
| MRQ (2024-3-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | 2020 (2020-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||
| Current Assets | ||||||||
| Cash Equivalents | 139.82M | 147.77M | 148.60M | 92.40M | 60.00M | |||
| Marketable Securities | 335.80M | 350.17M | 443.30M | 320.00M | 597.40M | |||
| Receivables | 131.16M | 114.02M | 75.20M | 20.20M | 10.80M | |||
| Inventories | 15.95M | 11.65M | 23.90M | 7.90M | 7.10M | |||
| Other Current Assets | 67.80M | 44.19M | 47.00M | 26.80M | 15.60M | |||
| Total Current Assets | 690.53M | 667.80M | 738.00M | 467.30M | 690.90M | |||
| Non-Current Assets | ||||||||
| PPE Net | 14.00M | 14.58M | 16.70M | 22.60M | 26.30M | |||
| Other Non-Current Assets | 42.51M | 45.91M | 100.00K | 100.00K | 100.00K | |||
| Total Non-Current Assets | 56.51M | 60.50M | 16.80M | 22.60M | 26.40M | |||
| TOTAL ASSETS | 747.04M | 728.29M | 754.80M | 489.90M | 717.30M | |||
| LIABILITIES | ||||||||
| Current Liabilities | ||||||||
| Short Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Accrued Expenses | 123.27M | 112.09M | 72.80M | 44.70M | 31.40M | |||
| Accounts Payable | 11.53M | 11.45M | 10.40M | 8.70M | 5.50M | |||
| Total Current Liabilities | 134.80M | 123.55M | 83.20M | 53.40M | 36.90M | |||
| Non-Current Liabilities | ||||||||
| Long Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Other Non-Current Liabilities | 12.74M | 13.33M | 15.50M | 18.70M | 23.60M | |||
| Total Non-Current Liabilities | 12.74M | 13.33M | 15.50M | 18.60M | 23.60M | |||
| TOTAL LIABILITIES | 147.54M | 136.87M | 98.70M | 72.00M | 60.50M | |||
| SHAREHOLDERS' EQUITY | ||||||||
| Retained Earnings | -1.63B | -1.62B | -1.48B | -1.22B | -937.10M | |||
| Additional Paid In Capital | 2.23B | 2.21B | 2.14B | 1.64B | 1.59B | |||
| Common Shares | 10.00K | 10.00K | 0.00 | 0.00 | 0.00 | |||
| Other Shareholders' Equity | -430.00K | 104.00K | -4.20M | -400.00K | 500.00K | |||
| Shares Outstanding | 97.48M | 96.38M | 94.80M | 81.90M | 80.50M | |||
| Tangible Book Value per Share | 6.15 | 6.14 | 6.92 | 5.10 | 8.16 | |||
| Total Shareholders' Equity | 599.50M | 591.42M | 656.10M | 417.90M | 656.90M | |||
| TOTAL LIABILITIES AND EQUITY | 747.04M | 728.29M | 754.80M | 489.90M | 717.30M | |||
| Statistics | ||||||||
| Current Ratio | 5.12 | 5.41 | 8.87 | 8.75 | 18.72 | |||
| Return On Assets (ROA) | -14.85% | -19.18% | -33.96% | -57.99% | -31.65% | |||
| Return On Equity (ROE) | -18.50% | -23.62% | -39.06% | -67.98% | -34.56% | |||
All data in USD